Prostate cancer: new discovery at IOR on resistance to hormonal therapies
My Science,
The Molecular Oncology research group, led by Prof. Andrea Alimonti at the Institute of Oncology Research (IOR, affiliated to…
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
Overview of attention for article published in Cancer Cell, September 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 23 Mendeley